Skip to main content
. 2021 Dec 18;21:351. doi: 10.1186/s12866-021-02401-0

Fig. 3.

Fig. 3

Difference in serum titer for the different severity. Group 1: SARS-CoV-2-N IgG antibody titer for 24 asymptomatic and mild cases; Group 2: SARS-CoV-2-N IgG antibody titer for 48 moderate cases; Group 3: SARS-CoV-2-N IgG antibody titer for 16 severe and critical cases. The significance of the difference was indicated using ‘* ‘(p < 0.05) and ‘*** ‘(p = 0.000)